Page 9 of 12
RSC Advances
DOI: 10.1039/C5RA25176A
(m, 3H), 3.86 (d, J = 11.2 Hz, 1H), 3.54ꢀ3.45 (m, 1H), 3.36 (d, J
6.70 (m, 2H), 5.17ꢀ5.06 (m, 1H), 2.82ꢀ2.52 (m, 2H), 2.08ꢀ1.39
= 10.9 Hz, 1H), 3.31 (d, J = 10.2 Hz, 1H), 2.02 (br s, 2H), 1.91ꢀ 60 (m, 6H), 1.72 (s, 3H), 1.64 (s, 3H), 1.34 (s, 3H). 13C NMR
1.66 (m, 2H), 0.94 (d, J = 6.8 Hz, 6H), 0.92 (d, J = 6.8 Hz, 6H).
13C NMR (CDCl3, 50 MHz): δ 106.35, 105.69, 71.88, 71.70,
64.28, 61.61, 32.82, 32.35, 17.31, 16.94. MS (EI; 70 eV) 146(0)
[M]⋅+, 145(1), 116(1), 103(100), 73(53), 57(63), 55(31), 43(42),
(CDCl3, 50 MHz): δ 154.09, 129.50, 127.33, 124.38, 121.22,
119.64 117.41, 76.02, 39.66, 31.06, 25.80, 24.37, 22.40, 22.24,
17.71. MS (EI; 70 eV) 230(52) [M]⋅+, 215(2), 187(20), 174(17),
5
161(27), 147(48), 133(20), 123(59), 107(94), 91(40), 81(40),
1
41(15). (I stereoisomer). MS (EI; 70 eV) 146(0) [M]⋅+, 145(1), 65 69(74), 55(16), 41(100). [cisꢀ3n] H NMR (CDCl3, 200 MHz): δ
116(2), 103(100), 73(54), 57(64), 55(33), 43(46), 41(17). (II
stereoisomer).
7.05 (d, J = 7.1 Hz, 2H), 6.88ꢀ6.69 (m, 2H), 3.05 (dd, J = 17.7,
7.9 Hz, 1H), 2.76 (d, J = 17.7 Hz, 1H), 2.08ꢀ1.20 (m, 7H), 1.21
(s, 3H), 0.97 (s, 3H), 0.65 (s, 3H). 13C NMR (CDCl3, 50 MHz): δ
154.64, 129.04, 126.81, 122.18, 119.94, 117.23, 75.36, 44.58,
10 cis/transꢀ(2ꢀIsopropylꢀ1,3ꢀdioxolanꢀ4ꢀyl)ꢀmethyl acetate 2g. 1H
NMR (CDCl3, 200 MHz): δ 4.73 (d, J = 4.6 Hz, 1H), 4.66 (d, J =
4.4 Hz, 1H), 4.37ꢀ4.18 (m, 2H), 4.17ꢀ3.98 (m, 3H), 3.91 (dd, J= 70 41.80, 39.71, 34.12, 32.41, 27.16, 23.74, 21.54, 18.23. MS (EI;
8.3, 6.9 Hz, 1H), 3.74 (dd, J= 8.3, 4.9 Hz, 1H), 3.58 (dd, J= 8.4,
6.7 Hz, 1H), 2.08 (s, 3H), 2.06 (s, 3H), 1.94ꢀ1.67 (m, 2H), 0.97ꢀ
15 0.88 (m, 12H). 13C NMR (CDCl3, 50 MHz): 170.89, 170.84,
109.02, 108.51, 73.70, 73.53, 67.27, 67.19, 64.72, 64.30, 32.06,
70 eV) 230(31) [M]⋅+, 214(4), 187(2), 173(1), 159(11), 145(17),
123(100), 107(39), 91(10), 81(30), 77(10), 67(12), 55(10), 43(9),
41(18). [transꢀ3n] 1H NMR (CDCl3, 200 MHz): δ 7.09 (d, J = 7.1
Hz, 2H), 6.81ꢀ6.72 (m, 2H), 2.73 (dd, J = 16.2, 6.7 Hz, 1H), 2.57
31.77, 20.89, 20.86, 16.93, 16.87, 16.59, 16.55. MS (EI; 70 eV) 75 (d, J = 16.4 Hz, 1H), 2.17ꢀ1.16 (m, 7H), 1.23 (s, 3H), 1.04 (s,
188(0) [M]⋅+, 187(0), 145(43), 115(1), 97(4), 86(1), 71(3), 61(4),
57(18), 43(100), 41(7). (I stereoisomer). MS (EI; 70 eV) 188(0)
20 [M]⋅+, 187(1), 145(46), 115(2), 97(45), 86(1), 71(4), 69(2),
57(19), 43(100), 41(7). (II stereoisomer). HRMS calculated for
C9H15O4 (MꢀH)+: 187.0970; found: 187.0967. ׀
ꢂ׀
= 1.6 ppm.
2ꢀHexyltetrahydrofuran 2i and 2ꢀpentyltetrahydroꢀ2Hꢀpyran
3H), 0.94 (s, 3H). 13C NMR (CDCl3, 50 MHz): δ 154.38, 129.75,
127.23, 122.72, 119.74, 117.15, 76.29, 48.19, 41.63, 40.13,
33.49, 32.22, 23.37, 20.80, 19.96, 19.91. MS (EI; 70 eV) 230(54)
[M]⋅+, 215(14), 187(10), 173(3), 159(26), 145(37), 123(100),
80 107(92), 91(21), 81(31), 77(17), 67(13), 55(18), 43(14), 41(32).
2ꢀMethylꢀ2ꢀ(2ꢀ(2,6,6ꢀtrimethylcyclohexꢀ1ꢀenꢀ1ꢀyl)ethyl)tetrahyꢀ
drofuran 2o.60 1H NMR (CDCl3, 200 MHz): δ 3.97ꢀ3.68 (m, 1H),
2.17ꢀ1.33 (m, 14H), 1.59 (s, 1H), 1.21 (s, 1H), 0.98 (s, 1H). 13C
NMR (CDCl3, 50 MHz): δ 137.12, 126.90, 82.88, 67.20, 41.13,
1
2i’.42,55 [THFꢀether/2i] H NMR (CDCl3, 200 MHz): δ 3.97ꢀ3.59
25 (m, 3H), 2.08ꢀ1.69 (m, 3H), 1.69ꢀ1.03 (m, 11H), 0.86 (t, J = 6.8
Hz, 3H). 13C NMR (CDCl3, 50 MHz): δ 79.59, 67.70, 35.89,
31.97, 31.51, 29.55, 26.50, 25.84, 22.73, 14.19. MS (EI; 70 eV) 85 40.05, 36.83, 35.22, 32.92, 28.78, 26.24, 25.48, 23.63, 19.84,
156(1) [M]⋅+, 138 (1), 96 (1), 81(1), 71(100), 55(6), 43(31),
41(31). [THPꢀether/2i’] 1H NMR (CDCl3, 200 MHz): δ 4.01ꢀ3.88
30 (m, 1H), 3.40 (td J= 10.9, 3.6 Hz, 1H), 3.29ꢀ3.08 (m, 1H), 2.17ꢀ
1.04 (m, 14H), 0.87 (t, J = 6.5 Hz, 3H). 13C NMR (CDCl3, 50
19.69. MS (EI; 70 eV) 236(2) [M]+., 221(2), 203(2), 177(4),
161(2), 149(2), 136(18), 123(15), 121(25), 107(15), 95(17),
93(17), 85(100), 81(14), 69(9), 67(10), 55(14), 43(52), 41(24).
1,7ꢀDimethoxyꢀ3,7ꢀdimethyloctane 2pa.23 1H NMR (CDCl3, 200
MHz): δ 78.08, 68.63, 36.78, 32.12, 32.09, 26.40, 25.36, 23.76, 90 MHz): δ 3.39 (t, J=6.7 Hz, 2H), 3.32 (s, 3H), 3.16 (s, 3H), 1.79ꢀ
22.77, 14.19. MS (EI; 70 eV) 156(1) [M]⋅+, 138 (1), 95 (1),
85(100), 67(16), 57(15), 43(21), 41(24).
1.20 (m, 9H), 1.12 (s, 6H), 0.88 (d, J=6.4 Hz, 3H). 13C NMR
(CDCl3, 50 MHz): δ 74.6, 71.2, 58.6, 49.1, 40.1, 37.7, 36.7, 30.2,
21.2, 19.6. MS (EI; 70 eV) 202(0) [M]+., 187(4), 138(11),
123(29), 109(14), 95(50), 81(95), 73(100), 55(94).
35 2ꢀPhenyltetrahydroꢀ2Hꢀpyran 2j.41 1H NMR (CDCl3, 200 MHz):
δ 7.39ꢀ7.15 (m, 5H), 4.36ꢀ4.24 (m, 1H), 4.12 (dd, J = 11.4, 3.5
Hz, 1H), 3.76ꢀ3.46 (m, 1H), 2.01ꢀ1.46 (m, 6H). 13C NMR 95 7ꢀEthoxyꢀ1ꢀmethoxyꢀ3,7ꢀdimethyloctane 2pb.23 1H NMR
(CDCl3, 50 MHz): 143.45, 128.38, 127.38, 125.95, 80.26, 69.11,
34.14, 26.02, 24.14. MS (EI; 70 eV) 162(54) [M]⋅+, 161 (46),
40 144(2), 133(4), 129(4), 115 (6), 105 (100), 91(29), 77(45), 65(8),
55(26), 51(19), 41(31).
(CDCl3, 200 MHz): δ 3.50ꢀ3.25 (m, 7H); 1.70ꢀ1.00 (m, 18H);
0.82 (d, J=6.4 Hz, 3H). MS (EI; 70 eV) 216(0) [M]+., 87(100),
59(59), 55(9), 45(13), 43(13), 41(9).
1ꢀMethoxyꢀ7ꢀpropyloxyꢀ3,7ꢀdimethyloctane 2pc.23 1H NMR
2ꢀMethylꢀ2,3ꢀdihydrobenzofuran 2l.56 1H NMR (CDCl3, 200 100 (CDCl3, 200 MHz): δ 3.39 (t, J=6.7 Hz, 2H), 3.31 (s, 3H), 3.23 (t,
MHz): δ 7.23ꢀ7.05 (m, 2H), 6.85 (dd, J = 7.4, 0.9 Hz, 1H), 6.77
(d, J = 7.9 Hz, 1H), 4.93 (ddq, J = 8.7, 7.7, 6.2 Hz, 1H), 3.32 (dd,
45 J = 15.4, 8.8 Hz, 1H), 2.82 (dd, J = 15.4, 7.7 Hz, 1H), 1.48 (d, J =
6.2 Hz, 3H). 13C NMR (CDCl3, 50 MHz): δ 159.63, 128.07,
J=6.7 Hz, 3H), 1.80ꢀ1.10 (m, 11H), 1.06 (s, 6H), 0.90ꢀ0.75 (m,
6H). MS (EI; 70 eV) 230(0) [M]+., 215(1), 101(74), 83(9), 69(7),
59(100), 55(11), 45(16), 43(21), 41(14).
7ꢀButoxyꢀ1ꢀmethoxyꢀ3,7ꢀdimethyloctane 1pd.23 1H NMR
127.15, 125.08, 120.28, 109.44, 76.52, 37.25, 21.88. MS (EI; 70 105 (CDCl3, 200 MHz): δ 3.40ꢀ3.10 (m, 7H); 1.70ꢀ1.00 (m, 22H);
eV) 134(100) [M]⋅+, 133(42), 119(66), 115(27), 113(34), 119(11),
107(100), 91(22), 77(25), 65(6), 51(13), 41(11).
0.82 (d, J=6.4 Hz, 3H). MS (EI; 70 eV) 244(0) [M]+., 229 (1),
115(55), 83(7), 69(7), 59(100), 55(10), 45(15), 43(10), 41(16).
1
50 2,2ꢀDimethylchromane 2m.57,58 1H NMR (CDCl3, 200 MHz): δ
7.15ꢀ7.05 (m, 2H), 6.90ꢀ6.70 (m, 2H), 2.80 (t, J = 6.7 Hz, 2H),
2ꢀMethoxyꢀ2ꢀmethyldecane 2qa. H NMR (CDCl3, 200 MHz): δ
3.17 (s, 3H), 1.52ꢀ1.37 (m, 2H), 1.37ꢀ1.20 (m, 12H), 1.12 (s, 6H),
1.83 (t, J = 6.7 Hz, 2H), 1.36 (s, 6H). 13C NMR (CDCl3, 50 110 0.88 (d, J=6.4 Hz, 3H). 13C NMR (CDCl3, 50 MHz): δ 74.79,
MHz): δ 153.48, 128.93, 126.73, 120.39, 119.08, 116.72, 73.56,
32.29, 26.37 (2), 21.94. MS (EI; 70 eV) 162(11) [M]⋅+, 147(17),
55 133(17), 119(40), 107(100), 91(5), 77(8), 51(8), 41(9).
49.20, 39.97, 32.06, 30.41, 29.79, 29.47, 25.12 (2), 24.03, 22.82,
14.26. MS (EI; 70 eV) 186(0) [M]+., 171(3), 73(100), 69(4),
55(8), 43(10).
1
2ꢀMethylꢀ2ꢀ(4ꢀmethylpentꢀ3ꢀenyl)chromane 2n and cis/transꢀ
2ꢀEthoxyꢀ2ꢀmethyldecane 2qb. H NMR (CDCl3, 200 MHz): δ
1,1,4aꢀtrimethylꢀ2,3,4,4a,9,9aꢀhexahydroꢀ1Hꢀxanthene 3n.59 [2n] 115 3.29 (q, J=7.0 Hz, 2H), 1.45ꢀ1.30 (m, 2H), 1.30ꢀ1.15 (m, 12H),
1H NMR (CDCl3, 200 MHz): δ 7.06 (d, J = 7.3 Hz, 2H), 6.88ꢀ
1.08 (t, J=7.0 Hz, 3H), 1.07 (s, 6H), 0.81 (d, J=6.4 Hz, 3H). 13C
This journal is © The Royal Society of Chemistry [year]
RSC Advances, [year], [vol], 00–00 | 9